Physician profile
Carolyn Quist
NPI 1649272972
$4,324.47
in general payments reported to CMS, 2019-2025
37 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,491 · 2020: $631 · 2021: $775 · 2022: $387 · 2023: $633 · 2024: $290 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,040.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,040.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $723.89 | 2019 | |
| Abbvie INC. | $563.08 | 2019-2022 | |
| Daiichi Sankyo INC. | $387.52 | 2019-2022 | |
| Astellas Pharma US INC | $279.82 | 2022-2025 | Veozah |
| Minerva Surgical, INC | $222.29 | 2019-2023 | |
| Amgen INC. | $205.59 | 2019-2021 | |
| Therapeuticsmd, INC. | $194.47 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $178.65 | 2021-2023 | |
| Lilly USA, LLC | $156.79 | 2019-2025 | Zepbound, Mounjaro |
| Millicent US INC | $149.48 | 2019-2023 | Intrarosa |
| Hologic Sales and Service, LLC | $142.58 | 2019-2020 | |
| Radius Health, INC. | $140.42 | 2021-2024 | Tymlos |
| Allergan, INC. | $139.86 | 2019-2020 | |
| Intuitive Surgical, INC. | $133.96 | 2023 | Da Vinci Surgical System |
| Virtus Pharmaceuticals LLC | $112.32 | 2021-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $80.60 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $54.24 | 2021-2024 | |
| Mycovia Pharmaceuticals, INC. | $52.64 | 2022-2023 | Vivjoa |
| Shield Therapeutics INC | $51.56 | 2023-2025 | Accrufer |
| Aspira Women'S Health INC | $44.61 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $40.40 | 2023-2025 | Myfembree |
| Amag Pharmaceuticals, INC. | $33.68 | 2019-2021 | |
| Alvogen INC | $24.97 | 2024 | Teriparatide |
| Azurity Pharmaceuticals, INC. | $20.12 | 2023 | Edarbi |
| Mylan Pharmaceuticals INC. | $19.89 | 2021 | |
| Vertical Pharmaceuticals, LLC | $19.82 | 2020 | |
| Agile Therapeutics, INC. | $19.72 | 2021 | |
| Urovant Sciences INC | $19.17 | 2022 | |
| Myovant Sciences INC. | $18.29 | 2021 | |
| Lsi Solutions INC | $17.39 | 2019 | |
| Organon LLC | $15.38 | 2024 | |
| Ascend Therapeutics US, LLC | $14.83 | 2024 | |
| Cumberland Pharmaceuticals, INC. | $11.90 | 2019 | |
| Merck Sharp & Dohme LLC | $11.55 | 2019 | |
| Vistapharm, INC. | $11.53 | 2021 | |
| Avion Pharmaceuticals | $11.46 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carolyn Quist listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.